Dura Substitute Market Size, Share & Analysis Report By 2030
The global Dura Substitute market gathered revenue around USD 176.1 Million in 2021 and market is set to grow USD 328.1 Million by the end of 2030 and is estimated to expand at a modest CAGR of 5.2% during the prediction period 2022 to 2030.
Growth Factors:
Prevalence of CNS tumors caused by neurological disorders is increasing. Chiari malformation and spinal cord tumor-related neurosurgery procedures that necessitate dural grafts have become more common.
Rise in prevalence of neurological diseases requires neurosurgical treatments as well as duraplasty for effective and safe treatment outcomes. In 2018, more than half of all dural substitutes were utilized in cranial and spine tumor surgeries. This is expected to continue in the near future. Therefore, rise in prevalence of neurosurgical diseases leads to an increase in cranial and spinal duraplasty procedures, which in turn is anticipated to boost the demand for dura substitutes.
Researchers have attempted to employ various synthetic polymers to make dural substitutes in order to minimize the spread of diseases caused by the use of allogeneic or xenogeneic materials, increase clinical effectiveness, and reduce costs
Synthetic macromolecular materials, in comparison to collagen-based dura substitutes, lack the biological functions of stimulating cell migration and boosting the production of related cytokines. Scientists have attempted to create dura substitutes by incorporating gelatin or silk fibroin into the polymer. This approach not only assures the bionic structure of the dural replacement, but also enhances the material's biological function and surface properties, improving its repair effects.
Therefore, benefits such as enhanced clinical effectiveness, increased safety, and minimal adverse effects associated with synthetic dura substitutes are anticipated to fuel the growth of the dura substitute market
Report Scope of the Dura Substitute Market
|
Report Coverage |
Details |
|
Market Size |
US$ 328.1 Million by 2030 |
|
Growth Rate |
CAGR of 5.2% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Material, Application, End-user and Region, |
|
Companies Mentioned |
Cook Medical LLC, B. Braun Melsungen AG, Integra LifeSciences, Cousin Surgery, W. L. Gore & Associates, Inc., Biosynth Lifesciences, Acera Surgical, Inc., Medprin, Medtronic, Stryker, DePuy Synthes, Gunze Limited, Baxter, Bennett Health, Inc., RTI Surgical, Natus Medical Incorporated |
Dura Substitute Market: Overview
Dural substitute is a type of medical device used in surgeries to repair dura mater, the outermost layer that covers and protects the brain. Animal collagen or nanofibers woven together with an elastic material to form a soft tamponade can also be used to create a dural substitute.
Dural substitutes are required to prevent CSF leaks and to allow dural openings to heal after surgery. Dural substitutes can be biological or synthetic, harvested from animals or human cadavers, and used as an onlay or suturable grafts. The key advantage of using a dural substitute is that it is similar to the patient's dura and can absorb and integrate into the host tissue.
Rise in the number of road accidents and sports injuries, which increases the need of neurosurgery, is the major factor boosting market growth. However, product recalls is likely to hamper market growth.
Government Funding in Regenerative Medicine Contributing to Market Growth
Government funding for the treatment of various diseases is increasing globally due to the formulation and adoption of supporting legislation & policies. Such trends are contributing to expansion of the regenerative medicine sector in the dura substitute market.
Healthcare companies are drawing significant expenditure in regenerative medicines such as the establishment of centers of excellence, manufacturing infrastructure, and research networks, among others. The NIH (National Institutes of Health) Common Fund facilitated the establishment of the NIH Center for Regenerative Medicine in 2010 with the purpose of serving as a national resource for stem cell sciences. Such developments are helping to accelerate the development of novel medical applications and cell-based therapeutics.
Transition from Animal Tissue-derived Materials to Synthetic Materials Aiding Market Growth
Dural repair materials are transitioning from animal tissue-derived materials to synthetic materials as well as from inert to absorbable properties. Such findings are bringing a significant change in the global dura substitute market.
Biomimetic patch is a new dural repair product that provides functional properties similar to alternate therapies. This patch has a 3 dimensional (3D) non-woven microfiber structure that is both mechanically strong and biocompatible. The animal investigation revealed that the biomimetic patch and commercially synthesized material groups demonstrated new subdural regeneration after 90 days, with low inflammatory response and minimal to no adhesion development at each stage. It has been found that the biomimetic structure and proper rate of degradation of the new absorbable dura replacement can lead significant regeneration of the dura mater.
Market Segmentation: Dura Substitute Market
In terms of material, the global dura substitute market has been bifurcated into biological graft and synthetic graft. The biological graft segment has been split into autografts, allografts, and xenografts. The synthetic segment has been segregated into polytetrafluoroethylene and others.
Based on application, the global dura substitute market has been classified into neurosurgery and spinal surgery
In terms of end-user, the global dura substitute market has been divided into hospitals, ambulatory surgical centers, and others
Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The dura substitute market report provides current and expected revenue (US$ Mn) for each of these segments from 2022 to 2030, considering 2021 as the base year. The compound annual growth rate (percentage CAGR) has been provided for each segment and market from 2022 to 2030 along with market size estimations.
Regional Overview: Dura Substitute Market
In terms of region, the global dura substitute market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa
North America dominated the global dura substitute market in 2021, accounting for 41.9% share. Developed healthcare infrastructure and presence of patient-specific healthcare systems fuel the growth of the dura substitute market in North America.
The U.S. dominated the market in North America due to rapid adoption of new technologies for soft tissue repair, presence of key players, and higher penetration of research activities across the country
Moreover, growing burden of neurosurgical diseases is leading to increase in cranial and spinal duraplasty, which, in turn, is likely to boost the demand for dura substitute in the region
Some of the prominent players in the Dura Substitute Market include:
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in Dura Substitute Market Study:
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers